Praill Anthony Scott 4
4 · DelMar Pharmaceuticals, Inc. · Filed Jun 30, 2020
Insider Transaction Report
Form 4
Praill Scott
CFO
Transactions
- Award
Option (Right to Buy)
2020-06-26+57,170→ 108,366 totalExercise: $0.61Exp: 2029-09-05→ Common Stock (57,170 underlying) - Other
Common Stock
2020-06-30+22→ 7,474 total
Footnotes (3)
- [F1]The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock.
- [F2]On September 5, 2019, the reporting person received options to purchase 57,170 shares which were subject to stockholder approval of the increase in the number of shares authorized for issuance under the DelMar Pharmaceuticals, Inc. 2017 Omnibus Equity Incentive Plan, as amended, at the 2020 Annual Meeting of Stockholders. Stockholder approval of the increase was obtained on June 26, 2020.
- [F3]1/6th of the options vested on March 5, 2020 with the remaining shares vesting in equal monthly installments over a period of 30 months which commenced on April 5, 2020.